Barry Ticho, CHIEF MEDICAL OFFICER at Stoke Therapeutics, Inc. (STOK), sold 7,176 shares at $28.95 ($208K) on 2026-08-03, disclosed to the SEC on 2026-08-05.
Scheduled sale ($208k) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.95 | 5,907 | $171K | 82.1% |
| 2 | $29.45 | 1,269 | $37K | 17.9% |
| Total | $29.04 avg | 7,176 | $208K | 100% |
| Filing → |
| STOK | SELL | 2026-08-18 | $153K | — | Filing → |
| STOK | SELL | 2026-07-06 | $236K | — | Filing → |
| STOK | SELL | 2026-06-03 | $55K | — | Filing → |